| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing concerns of lung cancer patients
|
Round, C.E.
|
|
1999
|
25 |
S1 |
p. S24-
1 p.
|
artikel
|
| 2 |
Adjuvant treatment of resected non-small cell lung cancer
|
Le Chevalier, T.
|
|
1999
|
25 |
S1 |
p. S6-S7
2 p.
|
artikel
|
| 3 |
Adrenal metastases in small cell lung carcinoma
|
Vaslamatzis, M.M.
|
|
1999
|
25 |
S1 |
p. S35-
1 p.
|
artikel
|
| 4 |
Analysis of survival data in non small cell lung cancer 1992–1997
|
Juhász, Erzsébet
|
|
1999
|
25 |
S1 |
p. S33-S34
2 p.
|
artikel
|
| 5 |
A phase II study with paclitaxel and gemsitabine in the treatment of patients with stage IIIB-IV non small cell lung cancer (NSCLC)
|
Ginopoulos, P.
|
|
1999
|
25 |
S1 |
p. S20-
1 p.
|
artikel
|
| 6 |
Application of molecular biology for early detection of lung cancer
|
Mulshine, J.L.
|
|
1999
|
25 |
S1 |
p. S1-S2
2 p.
|
artikel
|
| 7 |
Are the patients with metastatic non-small cell lung cancer curable?
|
Le Chevalier, T.
|
|
1999
|
25 |
S1 |
p. S8-
1 p.
|
artikel
|
| 8 |
Assessment of the diagnostic potential of ultrafast magnetic resonance imaging (MRI)
|
Bischoff, H.G.
|
|
1999
|
25 |
S1 |
p. S22-
1 p.
|
artikel
|
| 9 |
Author index
|
|
|
1999
|
25 |
S1 |
p. S45-S48
4 p.
|
artikel
|
| 10 |
Bilateral synchronous lung carcinoma
|
Radosavljevic-Asic, G.
|
|
1999
|
25 |
S1 |
p. S37-
1 p.
|
artikel
|
| 11 |
Bronchogenes carcinoma and smoking
|
Lazovic, N.
|
|
1999
|
25 |
S1 |
p. S29-
1 p.
|
artikel
|
| 12 |
Bronchoscopic follow-up after surgery for lung cancer
|
Kas, József
|
|
1999
|
25 |
S1 |
p. S39-
1 p.
|
artikel
|
| 13 |
Can the physician contribute to the decrease in prevalence of lung cancer?
|
Zellweger, Jean-Pierre
|
|
1999
|
25 |
S1 |
p. S15-
1 p.
|
artikel
|
| 14 |
Carboplatin and etoposide for small cell lung cancer in patients aged 70 years or over: impact of carboplatin dose on treatment results
|
Berzinec, P.
|
|
1999
|
25 |
S1 |
p. S34-S35
2 p.
|
artikel
|
| 15 |
Carboplatin and vinorelbine combination plus radiotherapy in advanced non small cell lung cancer (NSCLC)
|
Santoro, A.
|
|
1999
|
25 |
S1 |
p. S33-
1 p.
|
artikel
|
| 16 |
Cardiological finding in patients with lung cancer and Superior Vena Cava Syndrome (SVCS)
|
Vasic, N.
|
|
1999
|
25 |
S1 |
p. S38-
1 p.
|
artikel
|
| 17 |
Castelman lymphoma
|
Orosz, M.
|
|
1999
|
25 |
S1 |
p. S37-S38
2 p.
|
artikel
|
| 18 |
Central squamous cell carcinoma of the lung and its management by tranbronchoscopic therapy with interferon-γ and combination radiotherapy
|
Baka, S.
|
|
1999
|
25 |
S1 |
p. S32-
1 p.
|
artikel
|
| 19 |
Chemotherapy in Stage IV NSCLC
|
Manegold, C.
|
|
1999
|
25 |
S1 |
p. S5-S6
2 p.
|
artikel
|
| 20 |
Choroidal metastasis in non-small cell lung cancer: report of three cases
|
Bernardo, M.
|
|
1999
|
25 |
S1 |
p. S36-
1 p.
|
artikel
|
| 21 |
Cisplatin, etoposide and gemcitabine in small cell lung cancer (SCLC): a phase I study
|
De Marinis, F.
|
|
1999
|
25 |
S1 |
p. S34-
1 p.
|
artikel
|
| 22 |
Cisplatin, Ifosfamide and Vinorelbine combination in advanced non-small cell lung cancer
|
Barón, F.J.
|
|
1999
|
25 |
S1 |
p. S40-
1 p.
|
artikel
|
| 23 |
Cisplatin plus vinorelbine combined with radiation in locally advanced non-small cell lung cancer
|
Zatloukal, P.
|
|
1999
|
25 |
S1 |
p. S19-
1 p.
|
artikel
|
| 24 |
Clinical indications for bone scintigraphy in advanced lung cancer
|
Pavlović, S.
|
|
1999
|
25 |
S1 |
p. S36-
1 p.
|
artikel
|
| 25 |
Clinical indicators and diagnosis of mesothelioma during two-year period
|
Adžić, T.
|
|
1999
|
25 |
S1 |
p. S37-
1 p.
|
artikel
|
| 26 |
Clinical phase II trial of intravenous treosulfan in patients with non-pretreated metastatic small-cell lung cancer
|
Guschall, W.-R.
|
|
1999
|
25 |
S1 |
p. S34-
1 p.
|
artikel
|
| 27 |
Clinico radiological features of pleural mesotelioma
|
Stevic, R.
|
|
1999
|
25 |
S1 |
p. S37-
1 p.
|
artikel
|
| 28 |
Combined chemotherapy and radiation in NSCLC
|
Jassem, Jacek
|
|
1999
|
25 |
S1 |
p. S5-
1 p.
|
artikel
|
| 29 |
Comparison of cytogenetic biomarkers of effect in lung cancer cases and controls
|
Habalová, V.
|
|
1999
|
25 |
S1 |
p. S26-
1 p.
|
artikel
|
| 30 |
Comparison of krypton and technegas for quantiative ventilation perfusion scintigraphy
|
Hagen, P.J.
|
|
1999
|
25 |
S1 |
p. S39-
1 p.
|
artikel
|
| 31 |
Controlling the myelosuppressive side effects of cytostatics in lung cancer therapy by estimating the change of vitality of white blood cells - preliminary report
|
Valyon, Martha
|
|
1999
|
25 |
S1 |
p. S39-S40
2 p.
|
artikel
|
| 32 |
Correlation between aerosol deposition patterns and preferential sites of lung cancers in human and rat lungs
|
Balásházy, Imre
|
|
1999
|
25 |
S1 |
p. S38-S39
2 p.
|
artikel
|
| 33 |
Correlations of chemosensitivity tests on cultivated cells from malignant pleural effusions
|
Pešek, M.
|
|
1999
|
25 |
S1 |
p. S25-S26
2 p.
|
artikel
|
| 34 |
Current state of surgery for small cell lung cancer
|
Csekeõ, Attila
|
|
1999
|
25 |
S1 |
p. S10-S11
2 p.
|
artikel
|
| 35 |
Detection of musculoskeletal metastases of lung cancer using 99mTc-DPD and T1-201
|
Pavlović, S.
|
|
1999
|
25 |
S1 |
p. S35-
1 p.
|
artikel
|
| 36 |
Dose intensified chemotherapy with stem cell support in patients with small cell lung cancer; quantification of CD34+ cells in whole blood
|
Beigi, M.
|
|
1999
|
25 |
S1 |
p. S22-S23
2 p.
|
artikel
|
| 37 |
Early whole brain concurrent radiotherapy chemotherapy for non-small cell lung cancer brain metastases. A phase II study
|
Ngo Quy, C.
|
|
1999
|
25 |
S1 |
p. S21-
1 p.
|
artikel
|
| 38 |
Endobronchial BRT HDR in NSLC. Valuation early clinical results particular fractions
|
Maczko, M.
|
|
1999
|
25 |
S1 |
p. S30-
1 p.
|
artikel
|
| 39 |
Epidemiology of lung cancer. Why are there differences in geographical distribution?
|
Zatoński, Witold A.
|
|
1999
|
25 |
S1 |
p. S1-
1 p.
|
artikel
|
| 40 |
Evaluation of chest x-ray screening combined with sputum cytlogical examination of groups with risk factors
|
Lukács, J.
|
|
1999
|
25 |
S1 |
p. S28-S29
2 p.
|
artikel
|
| 41 |
Experience with Docetaxel in NSCC
|
Csada, E.
|
|
1999
|
25 |
S1 |
p. S43-
1 p.
|
artikel
|
| 42 |
Expression of angiogenic cytokines and their receptors in malignant mesothelioma
|
Tolnay, E.
|
|
1999
|
25 |
S1 |
p. S13-
1 p.
|
artikel
|
| 43 |
Future development of Taxotere in NSCLC
|
Blanc, Christine
|
|
1999
|
25 |
S1 |
p. S42-
1 p.
|
artikel
|
| 44 |
Gemcitabine and radiation therapy
|
Jungnelius, Ulf
|
|
1999
|
25 |
S1 |
p. S42-
1 p.
|
artikel
|
| 45 |
Gemcitabine and treatment of advanced NSCLC
|
van Zandwijk, Nico
|
|
1999
|
25 |
S1 |
p. S41-S42
2 p.
|
artikel
|
| 46 |
Gemcitabine chemotherapy in NSCLC experience from India
|
Behera, D.
|
|
1999
|
25 |
S1 |
p. S20-
1 p.
|
artikel
|
| 47 |
Gemcitabine combination with cisplatin in advanced non-small cell lung cancer
|
Thongprasert, Sumitra
|
|
1999
|
25 |
S1 |
p. S31-S32
2 p.
|
artikel
|
| 48 |
Gemcitabine, Ifosfamide and Cisplatin (GIP) in advanced stage III/IV non-small cell lung cancer (NSCLC)
|
De las Peñas, R.
|
|
1999
|
25 |
S1 |
p. S41-
1 p.
|
artikel
|
| 49 |
Gemcitabine in the treatment of advanced non small cell lung cancer in the elderly: preliminary report according to the multi-dimensional evaluation
|
Mattioli, R.
|
|
1999
|
25 |
S1 |
p. S32-S33
2 p.
|
artikel
|
| 50 |
Gemcitabine plus Cisplatin treatment for advanced NSCLC
|
Szondy, K.
|
|
1999
|
25 |
S1 |
p. S17-S18
2 p.
|
artikel
|
| 51 |
Gemzar and Oncovin: an effective regimen with low myelotoxicity in stage IV NSCLC
|
Zwitter, M.
|
|
1999
|
25 |
S1 |
p. S41-
1 p.
|
artikel
|
| 52 |
Gemzar monotherapy in advanced non-small cell lung cancer (NSCLC)
|
Gutorov, S.
|
|
1999
|
25 |
S1 |
p. S26-
1 p.
|
artikel
|
| 53 |
Genetic polymorphisms, allelic imbalance and point mutations of the MGMT gene in non-small cell lung cancer (NSCLC) patients
|
Rusin, Marek
|
|
1999
|
25 |
S1 |
p. S14-
1 p.
|
artikel
|
| 54 |
Genetic polymorphisms in GSTs and individual susceptibility to lung cancer
|
Wikman, H.
|
|
1999
|
25 |
S1 |
p. S14-S15
2 p.
|
artikel
|
| 55 |
Genetics of preneoplasia and lung cancer development
|
Gazdar, Adi F.
|
|
1999
|
25 |
S1 |
p. S2-S3
2 p.
|
artikel
|
| 56 |
Giant cell carcinoma of the lung with paraneoplastic hypereosinophilia
|
Kačar, V.
|
|
1999
|
25 |
S1 |
p. S38-
1 p.
|
artikel
|
| 57 |
Heat shock proteins (HSP70) expression in primary non-small cell lung carcinomas
|
Malusecka, Ewa
|
|
1999
|
25 |
S1 |
p. S27-
1 p.
|
artikel
|
| 58 |
High complication-rates with Palmaz-Stents for the palliative treatment of malignant tracheobronchial stenoses
|
Sahan, A.
|
|
1999
|
25 |
S1 |
p. S16-
1 p.
|
artikel
|
| 59 |
High dose rate endobronchial brachytherapy for malignant airway obstructions
|
Shin, K.H.
|
|
1999
|
25 |
S1 |
p. S19-
1 p.
|
artikel
|
| 60 |
Hyperperfractionated radiotherapy following induction chemotherapy for stage III non-small cell lung cancer (NSCLC) —randomized for adjuvant chemotherapy vs. observation
|
Choi, E.K.
|
|
1999
|
25 |
S1 |
p. S18-S19
2 p.
|
artikel
|
| 61 |
Hyperthermic pleural perfusion (HPP) with cisplatinum for the treatment of malignant pleural mesothelioma
|
Refaely, Yael
|
|
1999
|
25 |
S1 |
p. S25-
1 p.
|
artikel
|
| 62 |
Incidence of lung cancer in Denmark: historical and actual status
|
Skuladottir, H.
|
|
1999
|
25 |
S1 |
p. S12-
1 p.
|
artikel
|
| 63 |
Induction chemotherapy followed by radiotherapy for inoperable stage III non-small cell lung cancer in elderly patients
|
Berzinec, P.
|
|
1999
|
25 |
S1 |
p. S32-
1 p.
|
artikel
|
| 64 |
Intensive care for lung cancer patients
|
Sculier, Jean-Paul
|
|
1999
|
25 |
S1 |
p. S3-S4
2 p.
|
artikel
|
| 65 |
Interactive preventing method against smoking
|
Kovács, G.
|
|
1999
|
25 |
S1 |
p. S15-
1 p.
|
artikel
|
| 66 |
Lung cancer: a revolution in care
|
Jelsing, Nadine
|
|
1999
|
25 |
S1 |
p. S16-S17
2 p.
|
artikel
|
| 67 |
Lung cancer: recent advances and developments
|
Le Chevalier, Thierry
|
|
1999
|
25 |
S1 |
p. S42-S43
2 p.
|
artikel
|
| 68 |
Lung cancer screening reconsidered
|
Ostoros, Gy.
|
|
1999
|
25 |
S1 |
p. S39-
1 p.
|
artikel
|
| 69 |
Malignant pleural effusion in elderly patients
|
Zdravkovic, J.
|
|
1999
|
25 |
S1 |
p. S38-
1 p.
|
artikel
|
| 70 |
Mesothelioma of pleura in thorax surgery
|
Baško, J.
|
|
1999
|
25 |
S1 |
p. S25-
1 p.
|
artikel
|
| 71 |
Mesothelioma research news
|
Martinet, N.
|
|
1999
|
25 |
S1 |
p. S12-
1 p.
|
artikel
|
| 72 |
Metastases of primary lung carcinoma to abdominal organs
|
Stevic, R.
|
|
1999
|
25 |
S1 |
p. S36-
1 p.
|
artikel
|
| 73 |
MTA (LY231514): a phase II trial in patients (PTS) with non-small cell lung cancer (NSCLC) who relapsed after previous platinum or non-platinum chemotherapy
|
von Pawel, J.
|
|
1999
|
25 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 74 |
Navelbine, Ifosfamide and Cisplatin (NIP) combination as a treatment of non small cell lung cancer, Czech experience
|
Čertíková, G.
|
|
1999
|
25 |
S1 |
p. S40-
1 p.
|
artikel
|
| 75 |
Neoadjuvant treatment of N.S.C.L.C.
|
Filipazzi, V.
|
|
1999
|
25 |
S1 |
p. S17-
1 p.
|
artikel
|
| 76 |
Neoplastic disease as risk factor for pulmonary embolism
|
Nagorni-Obradovic, Lj.
|
|
1999
|
25 |
S1 |
p. S26-
1 p.
|
artikel
|
| 77 |
Neuroendocrine tumors of the lung: therapeutic approach
|
Ruggieri, M.
|
|
1999
|
25 |
S1 |
p. S23-
1 p.
|
artikel
|
| 78 |
NSCLC-IV initial treatment with 2 courses of chemotherapy
|
Radosavljevic-Asic, G.
|
|
1999
|
25 |
S1 |
p. S33-
1 p.
|
artikel
|
| 79 |
Occupational asbestos exposure and lung cancer
|
Posgay, M.
|
|
1999
|
25 |
S1 |
p. S12-
1 p.
|
artikel
|
| 80 |
Operation of a foetal type lung cancer
|
Juhász, M.
|
|
1999
|
25 |
S1 |
p. S38-
1 p.
|
artikel
|
| 81 |
Palliative radiation therapy: a feasible treatment for octogenarians diagnosed as having locally advanced NSCLC
|
Chang, Won
|
|
1999
|
25 |
S1 |
p. S19-
1 p.
|
artikel
|
| 82 |
Phase I-II trial of weekly paclitaxel in advanced non small cell lung cancer (N.S.C.L.C.): a preliminary report
|
Koumakis, G.
|
|
1999
|
25 |
S1 |
p. S31-
1 p.
|
artikel
|
| 83 |
Phase II study of Docetaxel and Cisplatin in a circadian timing as first line chemotherapy (CT) in advanced non small cell lung cancer (NSCLC)
|
Pawel, J.v.
|
|
1999
|
25 |
S1 |
p. S29-S30
2 p.
|
artikel
|
| 84 |
Phase II study of Gemcitabine (G) and Cisplatin (P) in advanced NSCLC. Focus on quality of life (QoL)
|
Jassem, J.
|
|
1999
|
25 |
S1 |
p. S24-
1 p.
|
artikel
|
| 85 |
Phase-II trial of Etoposide (E) and Carboplatin (CP) induction therapy (IT) followed by weekly Taxol (T) maintenance therapy (MT) in patients (PTS) with extensive stage small-cell lung cancer (SCLC-ED)
|
Garfield, D.
|
|
1999
|
25 |
S1 |
p. S23-
1 p.
|
artikel
|
| 86 |
Phase-II trial of taxotere (TXT) and Navelbine (N) as first-line therapy in patients (PTS) with advanced non-small cell lung cancer (ANSCLC)
|
O'Rourke, M.
|
|
1999
|
25 |
S1 |
p. S19-S20
2 p.
|
artikel
|
| 87 |
Polymorphism in gene for microsomal epoxide hydrolase as risk factor in lung cancer
|
Šalagovič, J.
|
|
1999
|
25 |
S1 |
p. S28-
1 p.
|
artikel
|
| 88 |
Polymorphism of DNA repair genes in lung cancer patients: a preliminary study
|
Butkiewicz, Dorota
|
|
1999
|
25 |
S1 |
p. S27-
1 p.
|
artikel
|
| 89 |
P53 protein expression in hyperplastic, metaplastic, preneoplastic and early neoplastic changes in the lungs resected due to primary cancer
|
Chyczewski, L.
|
|
1999
|
25 |
S1 |
p. S27-
1 p.
|
artikel
|
| 90 |
Prediction of influenza antibody titer following vaccination by CD4/CD8 ratio
|
Werneri, T.G.
|
|
1999
|
25 |
S1 |
p. S24-S25
2 p.
|
artikel
|
| 91 |
Preliminary results of a dose-intense phase II study of a combination chemotherapy regimen with Cisplatin (CDDP) and Epirubicin (EPI) including Medroxyprogesterone Acetate (MPA) and recombinant interleukin 2 (rIL-2) in patients with inoperable primary lung cancer
|
Mantovani, G.
|
|
1999
|
25 |
S1 |
p. S31-
1 p.
|
artikel
|
| 92 |
Premedication for the chemotherapy containing platin derivates
|
Spelda, S.
|
|
1999
|
25 |
S1 |
p. S36-S37
2 p.
|
artikel
|
| 93 |
Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer
|
Alhn, Y.C.
|
|
1999
|
25 |
S1 |
p. S18-
1 p.
|
artikel
|
| 94 |
Previous and new projects with Ifosfamid combinations - clinical results from the Thoraxklinik, Heidelberg
|
Manegold, C.
|
|
1999
|
25 |
S1 |
p. S40-
1 p.
|
artikel
|
| 95 |
Prognastic value of tumor size in patients with non-small cell lung cancer
|
Perin, B.
|
|
1999
|
25 |
S1 |
p. S29-
1 p.
|
artikel
|
| 96 |
Prognosis of surgical treatment of NSCLC patients by evaluation epidermal growth factor (EGF) and its receptor content in the tumour
|
Dykhno, A.Yu.
|
|
1999
|
25 |
S1 |
p. S28-
1 p.
|
artikel
|
| 97 |
Prognostic value of p53 gene mutations in NSCLC: negative impact in adenocarcinoma
|
Jassem, E.
|
|
1999
|
25 |
S1 |
p. S12-S13
2 p.
|
artikel
|
| 98 |
Pronostic factors of Synchronous Brain Metastasis (SBM) from lung cancer: a prospective study
|
Penel, N.
|
|
1999
|
25 |
S1 |
p. S35-S36
2 p.
|
artikel
|
| 99 |
P21WAF1 and bcl-2 expression in non-small cell lung cancer: association with p53 and prognosis
|
Niklinski, J.
|
|
1999
|
25 |
S1 |
p. S13-
1 p.
|
artikel
|
| 100 |
Quality assurance in pulomonary oncology
|
Eckhardt, Sándor
|
|
1999
|
25 |
S1 |
p. S4-S5
2 p.
|
artikel
|
| 101 |
Radiotherapy in resected NSCLC with a 3-D conformal planning system
|
Bischoff, H.G.
|
|
1999
|
25 |
S1 |
p. S18-
1 p.
|
artikel
|
| 102 |
Radiotherapy of NSCLC: current challenges and future directions
|
Price, Allan
|
|
1999
|
25 |
S1 |
p. S7-
1 p.
|
artikel
|
| 103 |
Randomized phase III trial of Taxol®/Carboplatin versus Taxol®Cisplatin in patients with advanced non-small cell lung cancer
|
Rosell, R.
|
|
1999
|
25 |
S1 |
p. S21-
1 p.
|
artikel
|
| 104 |
Results of surgery and chemotherapy in small cell lung cancer
|
Rea, F.
|
|
1999
|
25 |
S1 |
p. S23-
1 p.
|
artikel
|
| 105 |
Scintigraphy of the skeleton in preoperative staging of lung cancer patients
|
Stanojev, Dusica
|
|
1999
|
25 |
S1 |
p. S29-
1 p.
|
artikel
|
| 106 |
Sequential chemo-radiotherapy with cisplatin-vinorelbine in unresectable locally advanced non small cell lung cancer
|
Bover, I.
|
|
1999
|
25 |
S1 |
p. S32-
1 p.
|
artikel
|
| 107 |
Serum anti-p53 antiobodies in SCLC: the lack of clinical relevance
|
Jassem, E.
|
|
1999
|
25 |
S1 |
p. S27-
1 p.
|
artikel
|
| 108 |
Small cell lung cancer: a case record notes
|
Filipazzi, V.
|
|
1999
|
25 |
S1 |
p. S35-
1 p.
|
artikel
|
| 109 |
Small cell lung cancer: recent advances in combined modality therapy
|
Turrisi III, Andrew T.
|
|
1999
|
25 |
S1 |
p. S11-S12
2 p.
|
artikel
|
| 110 |
Smoking cessation: a study of respiratory in- and out-patients
|
Skwarski, K.M.
|
|
1999
|
25 |
S1 |
p. S15-
1 p.
|
artikel
|
| 111 |
Smoking habits of patients with lung carcinoma
|
Zakoska, M.
|
|
1999
|
25 |
S1 |
p. S26-S27
2 p.
|
artikel
|
| 112 |
Social cost of lung cancer in Switzerland
|
Priez, F.
|
|
1999
|
25 |
S1 |
p. S16-
1 p.
|
artikel
|
| 113 |
Staging and prognostic factors in NSCLC
|
Drings, Peter
|
|
1999
|
25 |
S1 |
p. S10-
1 p.
|
artikel
|
| 114 |
Statistical analysis of symptoms and quality of life data from a randomised lung cancer clinical trial
|
Qian, Wendi
|
|
1999
|
25 |
S1 |
p. S23-S24
2 p.
|
artikel
|
| 115 |
Surgical treatment of clinical N2 non-small cell lung cancer
|
Akopov, A.L.
|
|
1999
|
25 |
S1 |
p. S30-S31
2 p.
|
artikel
|
| 116 |
Syncronous and metachronous lung cancer
|
Csiszér, E.
|
|
1999
|
25 |
S1 |
p. S30-
1 p.
|
artikel
|
| 117 |
The impact of new agents in the management of stage III and IV non-small cell lung cancer. An overview
|
Hansen, Heine H.
|
|
1999
|
25 |
S1 |
p. S7-S8
2 p.
|
artikel
|
| 118 |
The infectious complications of bronchial cancer
|
Klastersky, J.
|
|
1999
|
25 |
S1 |
p. S12-
1 p.
|
artikel
|
| 119 |
The interferon system in lung cancer patients and new therapeutic approaches
|
Ambrus Sr., J.L.
|
|
1999
|
25 |
S1 |
p. S15-
1 p.
|
artikel
|
| 120 |
The potential role of Interleukin-8 in human malignant mesothelioma progression
|
GaIffy, Gabriella
|
|
1999
|
25 |
S1 |
p. S25-
1 p.
|
artikel
|
| 121 |
The relevance of new postsurgical TNM classification in NSCLC
|
Dziadziuszko, R.
|
|
1999
|
25 |
S1 |
p. S22-
1 p.
|
artikel
|
| 122 |
The resection of tracheal bifurcation for carcinomas
|
Davydov, M.
|
|
1999
|
25 |
S1 |
p. S17-
1 p.
|
artikel
|
| 123 |
The role of glutathione-related genes in lung cancer survival
|
Yang, P.
|
|
1999
|
25 |
S1 |
p. S14-
1 p.
|
artikel
|
| 124 |
The role of surgery for lung cancer at the end of the 2nd millenium
|
Motta, Giovanni
|
|
1999
|
25 |
S1 |
p. S6-
1 p.
|
artikel
|
| 125 |
The role of videothoracoscopy and videomediastinoscopy for lung cancer staging
|
Porhanov, V.
|
|
1999
|
25 |
S1 |
p. S21-S22
2 p.
|
artikel
|
| 126 |
The use of HLA-I class superficial effector molecules expression for the prognosis of surgical results in patients with non small cell lung cancer (NSCLC)
|
Polotsky, B.E.
|
|
1999
|
25 |
S1 |
p. S27-S28
2 p.
|
artikel
|
| 127 |
The use of 99Tcm-MIBI scintigraphy in patients with lung cancer
|
Bártfai, Z.
|
|
1999
|
25 |
S1 |
p. S22-
1 p.
|
artikel
|
| 128 |
Tissue saving vats resections for peripheral lung cancer
|
Porhanov, V.
|
|
1999
|
25 |
S1 |
p. S30-
1 p.
|
artikel
|
| 129 |
Transsternal approach for lung cancer surgery
|
Davydov, M.I.
|
|
1999
|
25 |
S1 |
p. S31-
1 p.
|
artikel
|
| 130 |
Treatment of brain metastases of lung cancer
|
Postmus, Pieter E.
|
|
1999
|
25 |
S1 |
p. S8-S10
3 p.
|
artikel
|
| 131 |
Treatment of non small cell lung cancer with Paclitaxel (TAXOL) in our clinical practice
|
Márk, Zsuzsa
|
|
1999
|
25 |
S1 |
p. S17-
1 p.
|
artikel
|
| 132 |
Treatment of patients with small cell lung cancer
|
Porhanov, V.
|
|
1999
|
25 |
S1 |
p. S34-
1 p.
|
artikel
|
| 133 |
Treatment of stage IIIB-IV non small cell lung cancer (NSCLC) with Gemcitabine, Ifosfamide, Cisplatin (GIP). A phase II study
|
Boni, C.
|
|
1999
|
25 |
S1 |
p. S40-S41
2 p.
|
artikel
|
| 134 |
Tumor vaccines in lung cancer: re-emergence of an old hypothesis
|
Palkonyay, Laszlo
|
|
1999
|
25 |
S1 |
p. S14-
1 p.
|
artikel
|
| 135 |
Value of cytological examinations in the diagnosis of lung cancer
|
Fijalkowski, M.
|
|
1999
|
25 |
S1 |
p. S28-
1 p.
|
artikel
|
| 136 |
VEGF plasma and bronchoalveolar lavage levels in lung cancer patients
|
Binder, D.
|
|
1999
|
25 |
S1 |
p. S13-S14
2 p.
|
artikel
|
| 137 |
Vinorelbine/Gemcitabine in advanced non-small-cell lung cancer
|
Pirker, R.
|
|
1999
|
25 |
S1 |
p. S20-
1 p.
|
artikel
|
| 138 |
Vinorelbine(NVB)-carboplatin(CBP) and mitomycin C (MMC)teniposide(VM26)-cisplati(CDDP)-lomustine(CCNU) alternating chemotherapy in the treatment of metastatic advanced non-small cell lung cancer (NSCLC)
|
Li, Jin Han
|
|
1999
|
25 |
S1 |
p. S17-
1 p.
|
artikel
|
| 139 |
Why evaluate the human cost of lung cancer?
|
Vannotti, M.
|
|
1999
|
25 |
S1 |
p. S16-
1 p.
|
artikel
|
Tijdschrift beschrijving